MREO: Mereo BioPharma Group plc - American Depositary Shares
今日MREO汇率已更改0.00%。当日,交易品种以低点0.38和高点0.40进行交易。
关注Mereo BioPharma Group plc - American Depositary Shares动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M30
- H1
- H4
- D1
- W1
- MN
MREO新闻
- Mereo BioPharma Group plc (MREO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Cantor Fitzgerald maintains Overweight rating on Mereo BioPharma stock
- Needham lowers Mereo BioPharma stock price target to $3 on trial data
- Five Below To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday - American Eagle Outfitters (NYSE:AEO), Apellis Pharmaceuticals (NASDAQ:APLS)
- Mereo BioPharma更新setrusumab项目,延长现金储备期限
- Mereo BioPharma updates setrusumab program, extends cash runway
- 美银证券下调Ultragenyx制药股票目标价,因临床试验失败
- BofA Securities lowers Ultragenyx Pharma stock price target on failed trials
- Leerink重申Ultragenyx Pharma股票评级为"优于大市"
- Ultragenyx Pharma stock rating reiterated at Outperform by Leerink
- 两项三期临床折戟致股价腰斩,杰富瑞看好Ultragenyx (RARE.US)2026年借候选药物反弹,给予“买入”评级
- Ultragenyx高管Huizenga出售价值2922美元股票
- Ultragenyx SVP Huizenga sells $2922 in shares
- RARE, MREO Tank as Osteogenesis Study Fails to Meet Primary Endpoint
- Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - ACM Research (NASDAQ:ACMR), ADS-TEC Energy (NASDAQ:ADSE)
- Jefferies下调Ultragenyx Pharma股票目标价至63美元,原因是临床试验失败
- Jefferies将Mereo BioPharma股票降级至"持有"评级,因setrusumab试验失败
- Jefferies lowers Ultragenyx Pharma stock price target to $63 on trial miss
- Jefferies downgrades Mereo BioPharma stock to Hold after setrusumab trial failure
- This Mereo BioPharma Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday - DigitalBridge Gr (NYSE:DBRG), Mereo BioPharma Group (NASDAQ:MREO)
- CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday - ACM Research (NASDAQ:ACMR), AST SpaceMobile (NASDAQ:ASTS)
- What's Going On With Ultragenyx Pharma Stock Tuesday? - Ultragenyx Pharmaceutical (NASDAQ:RARE)
- State Street To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday - Popular (NASDAQ:BPOP), CarGurus (NASDAQ:CARG)
- U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.51%
常见问题解答
MREO股票今天的价格是多少?
Mereo BioPharma Group plc - American Depositary Shares股票今天的定价为0.39。它在0.38 - 0.40范围内交易,昨天的收盘价为0.39,交易量达到714。MREO的实时价格图表显示了这些更新。
Mereo BioPharma Group plc - American Depositary Shares股票是否支付股息?
Mereo BioPharma Group plc - American Depositary Shares目前的价值为0.39。股息政策取决于公司,而投资者也会关注-82.67%和USD。实时查看图表以跟踪MREO走势。
如何购买MREO股票?
您可以以0.39的当前价格购买Mereo BioPharma Group plc - American Depositary Shares股票。订单通常设置在0.39或0.69附近,而714和0.00%显示市场活动。立即关注MREO的实时图表更新。
如何投资MREO股票?
投资Mereo BioPharma Group plc - American Depositary Shares需要考虑年度范围0.20 - 3.05和当前价格0.39。许多人在以0.39或0.69下订单之前,会比较11.43%和。实时查看MREO价格图表,了解每日变化。
Mereo BioPharma Group plc - American Depositary Shares股票的最高价格是多少?
在过去一年中,Mereo BioPharma Group plc - American Depositary Shares的最高价格是3.05。在0.20 - 3.05内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Mereo BioPharma Group plc - American Depositary Shares的绩效。
Mereo BioPharma Group plc - American Depositary Shares股票的最低价格是多少?
Mereo BioPharma Group plc - American Depositary Shares(MREO)的最低价格为0.20。将其与当前的0.39和0.20 - 3.05进行比较,可以发现潜在的长期切入点。观看MREO在图表上的实时走势以获取更多详细信息。
MREO股票是什么时候拆分的?
Mereo BioPharma Group plc - American Depositary Shares历史上曾经历过股票拆分。这些变化在公司行动后的、0.39和-82.67%中可见。
- 前一天收盘价
- 0.39
- 开盘价
- 0.39
- 卖价
- 0.39
- 买价
- 0.69
- 最低价
- 0.38
- 最高价
- 0.40
- 交易量
- 714
- 日变化
- 0.00%
- 月变化
- 11.43%
- 6个月变化
- -80.98%
- 年变化
- -82.67%